NEUE.Neuehealth, INC

Form 4: NeueHealth Director Kedrick D. Adkins Jr. Reports Stock Transaction

Sentiment:

SEC Form 4 Filing

📋All filings for Neuehealth, INC
🔒Login to Follow

Director Kedrick D. Adkins Jr. of NeueHealth, Inc. reports the vesting and acquisition of 10,500 shares of common stock through restricted stock units on May 13, 2025.

Summary

  • Kedrick D. Adkins Jr., a director of NeueHealth, Inc., filed a Form 4 with the SEC.
  • The filing reports a transaction that occurred on May 13, 2025.
  • Adkins acquired 10,500 shares of NeueHealth common stock through the vesting of restricted stock units.
  • The restricted stock units vested on May 13, 2025, one year from the grant date.
  • Following the transaction, Adkins directly owns 16,443 shares of NeueHealth common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency to investors regarding the actions of company insiders.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
05/13/2025Date of earliest transaction: vesting of restricted stock units and acquisition of common stock.
05/13/2025Vesting date of all 10,500 restricted stock units, one year from the grant date.
05/15/2025Date of signature for the Form 4 filing.

Keywords

Form 4, SEC Filing, Beneficial Ownership, Director, Kedrick D. Adkins Jr., NeueHealth, NEUE, Stock Transaction, Restricted Stock Units, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.